Easy Medibot Registers Patents for Uterine Elevation Robot in 19 European Countries
Easy Medibot, a subsidiary of WSI, has completed the registration of patents related to its surgical robot for uterine manipulation, 'Ubot,' in 19 European countries.
According to Easy Medibot on September 22, the recently registered patent pertains to technology for a uterine elevation robot and its control system. After receiving registration approval for the patent from the European Patent Office (EPO) in November of last year, Easy Medibot has been carrying out the country-by-country registration process.
Ubot is a surgical robot developed to adjust and stably maintain the position of the uterus during laparoscopic and robot-assisted gynecological surgeries. By incorporating voice recognition, remote control, and foot pedal technology, the system allows the surgeon to directly control the uterus without relying on an assistant. The company plans to realize a surgeon-centered uterine control system through this approach.
The company is currently preparing for electrical and mechanical safety testing required for domestic product approval. After conducting usability evaluation and completing the approval procedure, it aims to commercialize the product with a targeted release in the first half of next year.
Easy Medibot is also continuing to build its portfolio of intellectual property. It has completed registration of four patents domestically and filed an additional new patent for a modular, replaceable medical robot this year. Overseas, the company has filed a total of four patent applications, of which three have been registered and one is awaiting approval.
Hot Picks Today
Shocked While Looking for Jeonse... "A 30-Year-Old Apartment Costs 900 Million Won" Supply Halved in Northern Seoul [Real Estate AtoZ]
- "I Went for the Cheap Coffee, but Now I Feel Uneasy"... Major Coffee Franchises Cited for Violations One After Another
- "My Vicarious Satisfaction Every Night Gone: Sudden Deletion of Past Videos... Mukbang YouTubers Hit by Crackdown"
- Stars at the 45th and 47th Seconds... Only 7 Presidential Insiders Own the 'White House Rolex'
- "After Spending 170,000 Won on Hanwoo, This Is What I Got": Why Webtoon Artist Kim Gyusam Decided to Give Cash Instead
A company official stated, "Following domestic product approval, we are securing patents in key target countries in preparation for overseas market entry. Immediately after approval, we plan to begin preparations early next year to swiftly obtain FDA approval in the United States and CE certification in Europe."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.